News and Announcements
YPB Protects New Mamacare Export Range
- Published December 07, 2016 4:05PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
7th December 2016, ASX Announcement
- YPB protects exports of nutritional milk formula
- Growing uptake by Australian exporters of YPB’s products continues
Brand Protection and Customer Engagement solutions company YPB Group Limited (ASX: YPB) has commenced supply of YPB’s invisible tracer to MamaCare, a leading brand of premium pregnancy products including nutritional milk formula supplements and other well-being products for expectant and nursing mothers.
Mamacare will initially use YPB’s invisible tracer technology to Protect its export products, particularly the newly released export range of nutritional milk formula for pregnant women, as it experiences rapid growth distributing into Pan Asian markets.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
